CEACAM5 and lung cancer: Furthermore, to compare the diagnostic role of the new biomarker, we also analyzed 2 existing clinical biomarkers, CEA and CA 19-9, in lung cancer and healthy samples and compared their diagnostic efficacy with HSP70.